elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38586582-8EFB99C1-B87B-4CCF-94DC-9107B401CCDD
Q38586582-8EFB99C1-B87B-4CCF-94DC-9107B401CCDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38586582-8EFB99C1-B87B-4CCF-94DC-9107B401CCDD
Edoxaban: a review in nonvalvular atrial fibrillation.
P2860
Q38586582-8EFB99C1-B87B-4CCF-94DC-9107B401CCDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38586582-8EFB99C1-B87B-4CCF-94DC-9107B401CCDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09b2778cb118f5173a196be775142af4e3c09fd5
P2860
Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.